Search - tctmd.com

Displaying 141 - 160 of 196

Sort: Relevancy | Date

News Daily News

CMS Taking Another Look at Volume Requirements for TAVR Programs

Todd Neale

June 28, 2018

High-Quality TAVR: Does a Minimum Volume Requirement Still Make Sense?

Michael O'Riordan

June 22, 2018

News Conference News SCAI 2018

Heart Function, QoL Improvements at 1 Year in US Postapproval MitraClip Registry: PAS-1

Shelley Wood

April 27, 2018

News Daily News

‘Striking’ Rise in TAVR Among Patients With Previous CABG

Shelley Wood

April 13, 2018

News Daily News

Combining Frailty Index With Existing Risk Models Improves Mortality Prediction in TAVR

L.A. McKeown

February 22, 2018

News Daily News

Largest Study to Date Supports Surgical LAA Closure in A-fib Patients

Shelley Wood

January 23, 2018

News Daily News

Low Rate of Bailout Emergency Surgery During TAVR, but Caution Still Needed

Michael O'Riordan

January 10, 2018

News Daily News

Some Reassurances, Some Sobering Truths About Dialysis Needs After TAVR

Shelley Wood

October 16, 2017

News Conference News ESC 2017

LAACS: Surgical Closure of the Left Atrial Appendage Shows Promise

Shelley Wood

September 04, 2017

News Daily News

TAVR Equivalent to Surgery in Real-World Practice, New Analysis Shows

Michael O'Riordan

July 17, 2017

News Daily News

FDA Expands CoreValve Indication to Include Intermediate-Risk Patients

Michael O'Riordan

July 10, 2017

News Daily News

TAVR Use Triples in France, With Docs Treating Lower-Risk Patients

Michael O'Riordan

June 26, 2017

News Conference News TVT 2017

Volume Underload? More TAVRs Done, the Better the Operator Outcomes, Yet Many Patients Go Untreated

Michael O'Riordan

June 16, 2017

News Daily News

FDA Expands Sapien 3 Indication to Aortic, Mitral Valve-in-Valve Replacement

Michael O'Riordan

June 06, 2017

News Daily News

High-Volume Surgeons More Likely to Perform Durable Mitral Valve Repairs, Have Better Outcomes

Michael O'Riordan

May 04, 2017

News Daily News

Comrades in TAVR? Cardiac Surgeons Say They’re Involved in All Stages of TAVR Care

Yael L. Maxwell

April 14, 2017

News Conference News ACC 2017

MitraClip Commercial Experience at 1 Year Sheds Light on Progress and Lingering Concerns

L.A. McKeown

March 27, 2017

News Conference News ACC 2017

Add-on LAA Occlusion in Cardiac Surgery Cuts Thromboembolism Risk in A-fib Patients

L.A. McKeown

March 21, 2017

News Conference News ACC 2017

Live From Washington: ACC 2017, Day Three

Shelley Wood

March 19, 2017

News Daily News

Focused Update to Valve Guidelines Tackles Intermediate-Risk TAVR, Anticoagulation for A-fib

Todd Neale

March 15, 2017

Advertisement

CMS Taking Another Look at Volume Requirements for TAVR Programs

High-Quality TAVR: Does a Minimum Volume Requirement Still Make Sense?

Heart Function, QoL Improvements at 1 Year in US Postapproval MitraClip Registry: PAS-1

‘Striking’ Rise in TAVR Among Patients With Previous CABG

Combining Frailty Index With Existing Risk Models Improves Mortality Prediction in TAVR

Largest Study to Date Supports Surgical LAA Closure in A-fib Patients

Low Rate of Bailout Emergency Surgery During TAVR, but Caution Still Needed

Some Reassurances, Some Sobering Truths About Dialysis Needs After TAVR

LAACS: Surgical Closure of the Left Atrial Appendage Shows Promise

TAVR Equivalent to Surgery in Real-World Practice, New Analysis Shows

FDA Expands CoreValve Indication to Include Intermediate-Risk Patients

TAVR Use Triples in France, With Docs Treating Lower-Risk Patients

Volume Underload? More TAVRs Done, the Better the Operator Outcomes, Yet Many Patients Go Untreated

FDA Expands Sapien 3 Indication to Aortic, Mitral Valve-in-Valve Replacement

High-Volume Surgeons More Likely to Perform Durable Mitral Valve Repairs, Have Better Outcomes

Comrades in TAVR? Cardiac Surgeons Say They’re Involved in All Stages of TAVR Care

MitraClip Commercial Experience at 1 Year Sheds Light on Progress and Lingering Concerns

Add-on LAA Occlusion in Cardiac Surgery Cuts Thromboembolism Risk in A-fib Patients

Live From Washington: ACC 2017, Day Three

Focused Update to Valve Guidelines Tackles Intermediate-Risk TAVR, Anticoagulation for A-fib

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content